HOOKIPA Pharma Stock Price

-0.11 (-0.99%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
HOOKIPA Pharma Inc HOOK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.11 -0.99% 11.01 20:00:00
Close Price Low Price High Price Open Price Previous Close
11.01 10.86 11.425 11.32 11.12
Bid Price Ask Price Spread News
11.03 12.35 1.32 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,443 350,638 $ 11.03 $ 3,868,299 59,993 5.80 - 15.50
Last Trade Time Type Quantity Stock Price Currency
16:29:10 formt 105 $ 11.0117 USD

HOOKIPA Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 282.46M 25.65M 15.33M $ 11.94M $ - -1.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 12.10k 0.90%

more financials information »

HOOKIPA Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HOOK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.6213.45999.2110.62195,8221.3914.45%
1 Month9.8913.45998.1010.1290,8341.1211.32%
3 Months11.3313.45998.1010.4970,116-0.32-2.82%
6 Months7.4414.007.079.8472,2803.5747.98%
1 Year7.7215.505.8010.0574,5173.2942.62%
3 Years14.0115.505.809.6578,772-3.00-21.41%
5 Years14.0115.505.809.6578,772-3.00-21.41%

HOOKIPA Pharma Description

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.